Validation of a Medium-Throughput Method for Evaluation of Intracellular Growth of Mycobacterium tuberculosis

被引:33
作者
Eklund, Daniel [1 ]
Welin, Amanda [1 ]
Schon, Thomas [2 ]
Stendahl, Olle [1 ]
Huygen, Kris [3 ]
Lerm, Maria [1 ]
机构
[1] Linkoping Univ, Div Med Microbiol, Fac Hlth Sci, S-58185 Linkoping, Sweden
[2] Kalmar Cty Hosp, Dept Clin Microbiol & Infect Dis, S-39185 Kalmar, Sweden
[3] Sci Inst Publ Hlth, Program Immunol & Vaccinol, B-1180 Brussels, Belgium
基金
比尔及梅琳达.盖茨基金会; 瑞典研究理事会;
关键词
IN-VITRO; ANTIBIOTICS; LUCIFERASE; APOPTOSIS; DRUGS;
D O I
10.1128/CVI.00446-09
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Intracellular pathogens such as Mycobacterium tuberculosis have adapted to a life inside host cells, in which they utilize host nutrients to replicate and spread. Ineffective methods for the evaluation of growth of intracellular pathogens in their true environment pose an obstacle for basic research and drug screening. Here we present the validation of a luminometry-based method for the analysis of intramacrophage growth of M. tuberculosis. The method, which is performed in a medium-throughput format, can easily be adapted for studies of other intracellular pathogens and cell types. The use of host cells in drug-screening assays dedicated to find antimicrobials effective against intracellular pathogens permits the discovery of not only novel antibiotics but also compounds with immunomodulatory and virulence-impairing activities, which may be future alternatives or complements to antibiotics.
引用
收藏
页码:513 / 517
页数:5
相关论文
共 21 条
[1]   Apoptosis of monocytes and prolonged survival of granulocytes as a result of phagocytosis of bacteria [J].
Baran, J ;
Guzik, K ;
Hryniewicz, W ;
Ernst, M ;
Flad, HD ;
Pryjma, J .
INFECTION AND IMMUNITY, 1996, 64 (10) :4242-4248
[2]   Mycobacterial growth indicator tube for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin [J].
Bergmann, JS ;
Woods, GL .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 28 (03) :153-156
[3]   INHIBITION OF LYSOSOMAL PHOSPHOLIPASES BY AMINOGLYCOSIDE ANTIBIOTICS - INVITRO COMPARATIVE STUDIES [J].
CARLIER, MB ;
LAURENT, G ;
CLAES, PJ ;
VANDERHAEGHE, HJ ;
TULKENS, PM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (03) :440-449
[4]   In vitro detection of apoptosis in monocytes/macrophages infected with human coronavirus [J].
Collins, AR .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2002, 9 (06) :1392-1395
[5]   Improved tuberculosis DNA vaccines by formulation in cationic lipids [J].
D'Souza, S ;
Rosseels, V ;
Denis, O ;
Tanghe, A ;
De Smet, N ;
Jurion, F ;
Palfliet, K ;
Castiglioni, N ;
Vanonckelen, A ;
Wheeler, C ;
Huygen, K .
INFECTION AND IMMUNITY, 2002, 70 (07) :3681-3688
[6]   EFFECTS OF EXOGENOUS AMINES ON MAMMALIAN-CELLS, WITH PARTICULAR REFERENCE TO MEMBRANE FLOW [J].
DEAN, RT ;
JESSUP, W ;
ROBERTS, CR .
BIOCHEMICAL JOURNAL, 1984, 217 (01) :27-40
[7]   Bioluminescent Mycobacterium aurum expressing firefly luciferase for rapid and high throughput screening of antimycobacterial drugs in vitro and in infected macrophages [J].
Deb, DK ;
Srivastava, KK ;
Srivastava, R ;
Srivastava, BS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 279 (02) :457-461
[8]  
DICK T, 2009, KEYSTONE S GLOBAL HL, V25, P56
[9]   The early bactericidal activity of anti-tuberculosis drugs: a literature review [J].
Donald, P. R. ;
Diacon, A. H. .
TUBERCULOSIS, 2008, 88 :S75-S83
[10]   Global transcriptional profile of Mycobacterium tuberculosis during THP-1 human macrophage infection [J].
Fontan, Patricia ;
Aris, Virginie ;
Ghanny, Saleena ;
Soteropoulos, Patricia ;
Smith, Issar .
INFECTION AND IMMUNITY, 2008, 76 (02) :717-725